Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Open Orphan Plc ( (GB:HVO) ) is now available.
JPMorgan Asset Management Holdings Inc. has reduced its voting rights in hVIVO PLC to below the minimum threshold, as notified on January 30, 2025. This change in holding could signal a strategic shift in JPMorgan’s investment approach, potentially impacting hVIVO’s shareholder composition and market perception.
More about Open Orphan Plc
hVIVO PLC operates within the biotechnology industry, focusing on clinical trial services and research related to infectious and respiratory diseases. The company’s primary services include the development and testing of vaccines and antivirals, serving pharmaceutical companies and healthcare organizations globally.
YTD Price Performance: -7.32%
Average Trading Volume: 3,849,464
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £129.3M
See more insights into HVO stock on TipRanks’ Stock Analysis page.